Approximately $3 billion in Flexible Spending Account (FSA) funds are forfeited to employers every year because participants fail to spend their balances before the deadline. This is not merely a failure of accounting; it is a profound psychological weight that alters how we perceive our own bodies.

When the calendar nears its end, the human anatomy begins to look less like a biological system and more like a list of potential deductions. We start searching for ailments that fit our remaining balance, rather than searching for solutions that fit our ailments.

The Inversion of Discovery

Because the tax-advantaged status of a health savings account creates a “use-it-or-lose-it” psychology, the sequence of medical discovery is often turned on its head. In a quiet office in suburban Ohio, Marcus is currently experiencing this inversion.

Marcus has $214.60 remaining in his account. He has twelve days to spend it. The urgency of the expiring dollar has surpassed the urgency of his rising cholesterol, creating a scenario where the administrative eligibility of a test has become the primary gatekeeper of his curiosity.

This is the “Waiting Room of the Wallet,” a place I’ve spent twenty-three years observing from the perspective of a bankruptcy attorney. I see people at the end of their financial ropes, and I can tell you that the way Marcus is acting is entirely consistent with how the human mind handles “permissioned spending.”

In my line of work, I see clients who will fight tooth and nail to keep a $4,000 jet ski they haven’t used in three years simply because they feel they “earned” the right to own it, even as their primary residence is under threat. The “right to spend” is a powerful drug. For Marcus, the fact that a test is “eligible” for his health account provides a moral and financial shield. It justifies the purchase before he has even determined if the data it provides is something he is prepared to act upon.

Progress as a Legal Shield

Although Marcus knows that a laboratory report is not a diagnosis, the administrative “yes” of the insurance or tax code often feels like a clinical “yes.” It is a false sense of progress, which is also how a bankruptcy filing becomes a biography before it becomes a legal shield.

You start to define your health by what the system allows you to investigate. If the system allows Marcus to look at ten markers-total cholesterol, HDL, LDL, triglycerides, ApoA, ApoB, Lp(a), VLDL, hs-CRP, and homocysteine-he feels a sudden, intense need to know all ten. If the test only covered nine, he might feel he was being cheated of his balance.

Smoothing the Path to Spending

The commercial healthcare landscape has become incredibly efficient at smoothing this path. Services like

RxHomeTest

offer a way to bypass the traditional friction of a doctor’s visit by sending a kit directly to the home. The use of a finger-prick dried blood spot sample means there are no needles, no scheduling conflicts, and no sitting in a waiting room next to a man with a productive cough.

For Marcus, this convenience is the final piece of the justification puzzle. It’s not just that he can pay for it with his expiring funds; it’s that the physical effort required to do so is lower than the effort required to research whether he actually needs an ApoB test.

When we lower the barrier to entry for diagnostic information, we also lower the threshold for decision-making. In my office, I often see people who have signed contracts they didn’t read because the “Sign Here” flags were so conveniently placed.

Marcus finds himself looking at the Lipid Panel LP(a), APOB+ Test not because he had a long, nuanced conversation with his clinician about the limitations of standard lipid panels, but because the kit fits the $79.99 hole in his budget and the return shipping is free.

The Grocery List of Biomarkers

The markers themselves are fascinating, of course. ApoB (Apolipoprotein B) is increasingly recognized as a more precise measure of the number of atherogenic particles in the blood than a simple LDL-C count. Lp(a) is a genetically determined risk factor that doesn’t change much with diet or exercise, making it a “one-and-done” marker that can provide a baseline for cardiovascular risk.

But for Marcus, these technical nuances are secondary to the administrative relief of clicking “Buy Now.” He is treating the laboratory markers like items on a grocery list that must be cleared out before the store closes.

Because the administrative eligibility is established first, the personal suitability of the test is often rationalized after the fact. Marcus tells himself that he “needs to be proactive,” which is a noble-sounding phrase that often hides a lack of specific goals.

In bankruptcy law, we call this “asset shuffling”-moving things around to create the appearance of stability without actually addressing the underlying debt. Marcus is moving data points from a lab report to his mental ledger, hoping that the mere possession of the numbers will equate to the possession of health.

The Souvenir of a Deadline

The report he will receive from a CLIA-certified laboratory will be easy to read and will likely show him where he stands relative to standard ranges. This is a valuable service, provided the user knows what to do with the information. However, the danger of the current model is that the “easy-to-read report” becomes the end goal. Marcus is chasing the feeling of “knowing” without the commitment of “changing.” He is more interested in the receipt than the result.

This inversion of priorities is a tax on the indecisive. The commercial system understands that if you make it easier to establish eligibility than suitability, people will default to spending. It’s a brilliant bit of architectural nudging.

By the time Marcus actually gets his results and sits down with a clinician, the financial transaction is long over. The clinician is then put in the position of having to interpret a panel that they didn’t order, for a patient who might not have needed it, all because an FSA balance was ticking down to zero on a Tuesday in December.

I recently cracked my neck too hard while leaning over a pile of discharge papers, and the resulting stiffness has made me irritable about the way we prioritize our physical and financial health. We treat our bodies like liabilities to be managed rather than assets to be cultivated. We look for the “coverage” before we look for the “cure.”

Marcus will eventually get his results. He will see his hs-CRP (high-sensitivity C-reactive protein) levels and wonder if that inflammation is from his diet or just the stress of his job. He will look at his homocysteine levels and try to remember what a “normal” range looks like.

But the original sin of the decision-the fact that it was driven by a budget rather than a biological question-will remain. We must ask ourselves if we are ordering tests because we are curious about our health or because we are afraid of wasting our money. The two motivations feel similar in the moment, but they lead to very different places.

One leads to a conversation with a doctor about risk stratification and lifestyle intervention; the other leads to a PDF sitting in an inbox, a digital souvenir of a fiscal deadline met. In the end, Marcus will feel a sense of accomplishment. He saved his $214.60 from being forfeited. He has a 10-marker panel on its way to his house.

“The most expensive thing you can buy is a piece of information you aren’t ready to use.”

Administrative eligibility is a low bar to clear; personal suitability is the much higher one. We would do well to remember which one should come first. The commercialization of the lab-the transition from the sterile, inaccessible hospital wing to the kitchen table-is a victory for autonomy.

But autonomy requires a level of discipline that many of us, caught in the gears of the financial year, find difficult to maintain. We are given the tools to be our own advocates, but we often end up being our own accountants instead.

Marcus is a good man, a careful man, but he is currently a man who is letting a tax code dictate the rhythm of his heart health. And in the world of debt and blood, the tax code is a very poor doctor.